The FDA has approved Takeda’s new immunoglobulin therapy, Gammagard liquid ERC [immune globulin infusion (human)], to treat ...

Scientists are hopeful a supercharged weather forecaster will be one of the winners in the biggest overhaul of the science ...

Bristol-Myers Squibb faces revenue declines but offers long-term potential via growth drugs. Read what BMY stock has to offer ...

The U.S. Nuclear Regulatory Commission announced it is moving forward to advance new uses of factory-built microreactors for ...

A charismatic 33-year-old Indian-American politician from New York called Zohran Kwame Mamdani is creating waves of upset – ...

The history of the world is far deeper, broader, and stranger than just political backstabbing, epic battles, and dusty ...

More than seven out of 10 U.S. adults give a grade of C or worse to K-12 public schools' efforts to prepare students "to be ...

“An ounce of prevention is worth a pound of cure,” as the saying goes. Yet high-quality preventive care is out of reach for ...

Power plants and industrial facilities that emit carbon dioxide, the primary driver of global warming, are hopeful that ...

When two state senators entered the race for mayor of New York City – where’d they find the time? It came from you.They spent ...

Zhuang Deshui, deputy head of Peking University's Research Center of Public Policy, emphasized the importance of grassroots ...